DocGo (DCGO) to Release Quarterly Earnings on Monday

DocGo (NASDAQ:DCGO) will likely be announcing its Q4 2025 results after the market closes on Monday, March 16th. Analysts expect the company to announce earnings of ($0.09) per share and revenue of $70.3560 million for the quarter. Parties can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Monday, March 16, 2026 at 5:00 PM ET.

DocGo Price Performance

DCGO opened at $0.66 on Friday. The stock’s 50 day moving average price is $0.78 and its 200 day moving average price is $1.04. The stock has a market cap of $64.28 million, a P/E ratio of -1.26 and a beta of 0.95. DocGo has a 12 month low of $0.60 and a 12 month high of $3.00.

Analysts Set New Price Targets

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of DocGo in a research note on Monday, December 29th. One investment analyst has rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, DocGo currently has an average rating of “Hold” and an average target price of $2.25.

Hedge Funds Weigh In On DocGo

A number of institutional investors and hedge funds have recently added to or reduced their stakes in DCGO. Boothbay Fund Management LLC boosted its position in shares of DocGo by 39.0% during the 4th quarter. Boothbay Fund Management LLC now owns 200,947 shares of the company’s stock valued at $176,000 after purchasing an additional 56,413 shares in the last quarter. Oxford Asset Management LLP raised its stake in DocGo by 122.6% during the 2nd quarter. Oxford Asset Management LLP now owns 93,126 shares of the company’s stock valued at $146,000 after purchasing an additional 51,298 shares during the period. Empowered Funds LLC lifted its stake in DocGo by 14.6% in the 4th quarter. Empowered Funds LLC now owns 138,306 shares of the company’s stock worth $121,000 after acquiring an additional 17,607 shares in the last quarter. BNP Paribas Financial Markets lifted its position in shares of DocGo by 411.3% in the third quarter. BNP Paribas Financial Markets now owns 81,482 shares of the company’s stock worth $111,000 after purchasing an additional 65,545 shares in the last quarter. Finally, Wells Fargo & Company MN boosted its stake in shares of DocGo by 44.3% during the 4th quarter. Wells Fargo & Company MN now owns 100,811 shares of the company’s stock valued at $88,000 after buying an additional 30,957 shares during the period. 56.44% of the stock is owned by institutional investors.

About DocGo

DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.